Search

Laboratory test

Blood Bank / Transfusion Medicine

Weak D Testing

Weak D Testing is a Blood Bank / Transfusion Medicine laboratory test reference in the LabPedia Medical Laboratory Library. Indirect antiglobulin (or equivalent) phase testing for weak RhD expression when direct anti-D typing is negative or discrepant; policies differ for patients vs donors.

Also known asDu testing (historical); Weak D IAT; Weak D workup

Overview

Weak D testing detects reduced D antigen expression that may not agglutinate at immediate spin with anti-D but reacts after AHG or on sensitive platforms.

Clinical Importance

Resolve apparent D− results when policy requires weak D detection (often donors; variable for patients)

Guide RhD labeling and selected perinatal decisions alongside molecular testing when indicated

Specimen Requirements

  • Specimen: whole blood (EDTA preferred for most typing, screens, and crossmatches)
  • Tube: lavender/pink-top K₂EDTA (follow institutional blood bank tube color policy)
  • Identity: two unique patient identifiers; many sites require a witnessed/type-and-screen collection process
  • Handling: mix gently; do not use grossly hemolyzed specimens for serologic interpretation without investigation
  • Timing: specimen age limits for pretransfusion testing are SOP-/standards-defined (commonly ≤3 days for patients who may have been transfused or pregnant recently; verify local AABB-aligned policy)

Analytical Method

Red cells are incubated with anti-D, washed, and tested with AHG (tube) or read in gel/solid-phase weak D protocols. Molecular RHD genotyping increasingly stratifies weak vs partial D for transfusion/RhIG decisions.

Instruments Used

Automated analyzers

  • Ortho Vision / Ortho Clinical Diagnostics automated immunohematology systems
  • Bio-Rad IH-1000 / IH-500 and related gel/column systems
  • Grifols Erytra / Wadiana automated blood typing systems
  • Immucor NEO / Echo luminescent immunohematology systems
  • Manual tube testing with centrifugation and macroscopic reading
  • Column agglutination (gel/bead) card systems
  • Solid-phase red cell adherence platforms

Manual methods

  • Manual tube testing with immediate-spin and AHG phases as applicable

Reference Values

Immunohematology interpretations follow institutional SOPs aligned with AABB Standards, ISBT terminology, and applicable CLSI / BSH guidance. Reagent lots, method (tube, gel, solid-phase), and patient history critically affect results; always verify against the performing laboratory’s current procedure and applicable standards edition.

Categorical: weak D detected or not detected. Interpretation for transfusion as D+ vs D− is policy- and patient-category-specific (AABB/BSH-aligned institutional rules).

Interpretation

Common Causes of Increased Results

  • Weak D positive; donor units typically labeled RhD positive; patient management follows local weak/partial D policy

Common Causes of Decreased Results

  • Weak D not detected; remains RhD negative by serologic weak D protocol

Clinical Significance

  • Donor confirmation pathways
  • Selected patient discrepancy resolutions
  • Perinatal D typing algorithms when molecular testing is unavailable

Factors Affecting Results

Pre-analytical

  • Patient misidentification or unlabeled/mislabeled specimens
  • Wrong tube type or clotted EDTA specimen when plasma is required
  • Specimen older than institutional pretransfusion dating limits
  • IV fluid contamination or draw above an infusion

Analytical

  • Omitting AHG phase when required
  • Confusing weak D with partial D clinically

Post-analytical

  • Applying donor weak D rules to obstetric patients incorrectly

Advantages and Limitations

Advantages

  • Detects many serologically weak D phenotypes

Limitations

  • Does not fully replace RHD genotyping for partial D risk
  • Policy-dependent clinical meaning

Clinical Pearls

Weak D in a donor and weak D in a pregnant patient are different policy questions; do not copy-paste the label logic.

Related Laboratory Tests

References

Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.

Textbooks

  • Cohn CS, Delaney M, Johnson ST, Katz LM, eds. Technical Manual. 21st ed. AABB; 2023.
  • Fung MK, Eder AF, Spitalnik SL, Westhoff CM, eds. Technical Manual. 20th ed. AABB; 2020.
  • Harmening DM. Modern Blood Banking & Transfusion Practices. 7th ed. F.A. Davis; 2019.
  • McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Elsevier; 2021.
  • Bain BJ, Bates I, Laffan MA, eds. Dacie and Lewis Practical Haematology (verify current edition). Blood transfusion chapters.

CLSI and Professional Guidelines

  • AABB. Standards for Blood Banks and Transfusion Services (verify current edition and institutional adoption).
  • U.S. Food and Drug Administration. Code of Federal Regulations Title 21 . Blood and Blood Components (verify current institutional adoption).
  • World Health Organization. Blood safety and availability / transfusion guidance (verify current WHO publication and institutional adoption).
  • Clinical and Laboratory Standards Institute. Related immunohematology and specimen identity standards (verify current documents and institutional adoption).
  • International Society of Blood Transfusion (ISBT). Blood group terminology and transfusion guidance (verify current ISBT publications).
  • British Society for Haematology (BSH). Guidelines for blood grouping, antibody testing, and transfusion practice (verify current BSH guideline editions).
  • Clinical and Laboratory Standards Institute. Immunohematology, specimen identification, and related transfusion laboratory documents (verify current CLSI editions).

WHO Publications

  • World Health Organization. Blood safety, availability, and clinical transfusion guidance (verify current WHO publication).

Frequently Asked Questions

Common questions about using this Weak D Testing laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.

What is the Weak D Testing laboratory test reference used for?

This Medical Laboratory Library page summarizes the clinical importance of Weak D Testing. Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.

Where can I find Weak D Testing specimen requirements?

See the Specimen Requirements section on this page for specimen information related to Weak D Testing. Confirm collection details against your laboratory protocol.

Where are Weak D Testing reference values listed?

See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.

How do I interpret Weak D Testing results?

Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.

What analytical method is used for Weak D Testing?

See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.

Are related laboratory tests linked from Weak D Testing?

Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.

How can I continue learning after reading Weak D Testing?

Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Blood Bank / Transfusion Medicine topic.

What are the clinical pearls for Weak D Testing?

See the Clinical Pearls section for concise laboratory practice notes associated with Weak D Testing. Apply pearls alongside institutional protocols.

Reading progress

Awards XP once after you have meaningfully reviewed this article.